Zafgen Inc. appointed Brian McVeigh as chief business officer, effective May 29.
Previously, McVeigh served as vice president of world wide business development, transactions and investment management at GlaxoSmithKline PLC in pharmaceuticals research and development from October 2011 until November 2017.
Boston, Mass.-based Zafgen is a clinical-stage biopharmaceutical company, which develops therapies for patients suffering from metabolic diseases comprising type 2 diabetes, Prader-Willi syndrome, and other metabolically related disorders.
